Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-20

Clinical Trial Update: D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia [NA]

View source ↗

Summary

Clinical trial of D-cycloserine added to cognitive remediation for schizophrenia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-cycloserine (D-cycloserine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | NA | Status: COMPLETED | Results posted: 2014-08-20